Publication Ethics

Publication ethics are the principles that guide us to make Acquire the best.

Publication Ethics

Ethical standards of high-grade confirms the legitimacy of the scientific publication and conquests the community faith on novel and scientific innovations in such a manner that it augments the trustworthiness and reliability of the research work or abstraction. We follow the guidelines and standard put forward by COPE.


Acquire takes note of unique research papers that has neither been published somewhere else, nor under process of reviewing for publication. Acquire adhere authenticated software tool to notice comparable and similar or alike data in the submitted Manuscripts. Manuscripts that are found to have been plagiarized from the manuscripts of other authors whether published or unpublished, would be summarily rejected and the authors may incur sanctions, Manuscripts which does not meet the required criteria are also rejected based on the suggestions of reviewers.

Duplicate submission and redundant publication

Acquire journals consider only original articles i.e articles that have been not published elsewhere. A publication is considered as duplicate submission when the content or information or data in the manuscripts is similar or overlaps or relates fundamentally with another article that is already been published/in press, or under consideration/submission. Redundant publication, the unsuitable division of study results into more than one article (also known as salami slicing), may result in rejection or a request to combine submitted manuscripts, and the correction of published articles. International copyright laws, ethical conducts, and cost-effective use of resource ensure originality of the manuscript submitted.

Manuscripts must be original and should not have published or submitted elsewhere while it’s under consideration for publication with a publisher. According to the APA code of ethics (APA Publication Manual, 2010) duplicate publication is violation of publication ethics and will be rejected.

If the author has any queries regarding re-using of a figure published somewhere else or that has been copyrighted, then author should take suggestion from the editorial board members that is reviewing their manuscript. In such situations, author must provide testament from the earlier publisher or the copy right holder’s permission for the figure to be re-published. In such state of affairs if the author was not aware of the violation of the code and the material has been published, then actions must be taken to correct the same by submitting the manuscript with necessary amendments to rectify the ethical violation. Acquire journals will consider extended forms of articles published at conferences on condition that this is acknowledged in the cover letter, the former version is evidently cited and deliberated, there is significant new content, and any necessary permissions are obtained.

Citation Manipulation

Any Submitted article which is found to contain citations with an intention to increase the number of citations of a specified author, it will be measured as citation manipulation.

Data Falsification or Fabrication

If the submitted articles are recognized as fabricated or falsified with the investigational results or outputs containing altered or manipulated images, it is measured as falsification or fabrication.

Authorship and acknowledgements

All listed or stated authors should have performed a noteworthy contribution towards the research work submitted and must be approving all its claims. It is essential to list out the particular individual who made significant contribution, including the students/ scholars/ academicians or any laboratory technicians. Modifications in authorship must be declared to the journal and agreed to by all authors. Submissions by any person other than one of the authors will not be calculated.

Any person who contributed to the research or manuscript preparation, but is not an author, should be acknowledged with their consent.

Conflicts of interest (COI)

In order to uphold comprehensibility and support readers to form their own judgements of potential bias, authors should declare any competing financial interests related to the work described or presented.

During submission, policy demands that every single author must disclose financial interests, funding and other payments or collaborations, which may be direct or indirect and may raise the question of conflict or bias in the submitted work or in the conclusions, opinions given or consequences, or any other sources of funding for related work from an organization with an interest in the outcome of the work. Authors should also state in their document regarding if there are patents or trademarks owned by someone or their organization, personal, professional relationship or someone whose work is critiqued in order not to affect in the peer review process, beliefs or activism, for example, political or religious, relevant to the work.

However, in the case of accepted manuscript, Conflict of Interest statement should be stated in the manuscript.

Permissions to reproduce previously published material

Permission is important to reproduce material or article from the copyright holder. Reproduces articles cannot be directly published without these permissions.

Patient consent forms

It is very important to guard patient’s right to confidentiality. Thoughtfully collect and safeguard copies of patient’s consent forms that remark patients or other themes of your experiments clearly. Take utmost attention to protect their identities or personalities while submitting the manuscript for publication as photographs or any other material that may determine the specified individual. If the consent forms are not obtained, then, it is requested to obtain one or to remove the elements that may reveal the individual identities from the document. However, the obtained statement must be included in the ‘Methods’ section of your manuscript. If necessary, the Editors may request a copy of the consent forms.

Ethics committee approval

All the manuscripts dealing with the original human or animal data should include a statement on ethics approval at the beginning of the Methods section. Similarly, should encompass the stated information: the name and the address of the responsible ethics committee, the protocol number, along with the date of approval that is attributed by the ethics committee mentioned.

The paragraph can declaim, for example:
"Ethical approval for this study was given by the Ethical Committee of specific University or Hospitals, of certain place, on specific date."

Additionally, as featured above for the studies carried on human participants, it is important to state transparently that you have attained the written consent from the participants that s/he has read and understood the specifics and they are participating in it with their personal consent. Please, go through the up-to-date version of the Declaration given by the particular organization. Similarly, trials that involve animals, authors must furnish the state of animal care and licensing guidelines under which the study was performed and is reported. This should be provided in accordance with the ARRIVE statement (Animals in Research: Reporting In Vivo Experiments). In any case, if ethics clearance was not obligatory or if there was any deviation or change from the standard of ethical requests, it is required to state the specified reason. Despite this, kindly note that the editor/s might ask you to provide evidence of ethical approval. In addition, if you have approval from a National Drug Agency (or similar) please state this and provide details, this can be particularly useful when discussing the use of unlicensed drugs.